Los Angeles-based Cedars-Sinai Medical Center partnered with Boston-based organs-on-chip provider Emulate to establish a precision medicine program, the organizations confirmed Feb. 20.
Innovation
Genomics companies in the U.S. received $2.52 billion in venture capital funding in 2017, up 142 percent from $1.04 billion in 2016, according to a joint report by PwC and CB Insights.
The number of consumers who underwent direct-to-consumer genetic testing surpassed 4 million in 2017, almost double the 2.6 million who reported doing so in 2016, according to an analysis by MIT Technology Review senior editor for biomedicine Antonio Regalado.
An artificial intelligence algorithm developed by Google Research may be able to predict a patient's risk of heart attack or stroke, according to a study published in Nature Biomedical Engineering Feb. 19.
Researchers are looking for alternate possibilities for CRISPR, a technology that can edit a living organism's DNA, according to Gizmodo.
Advertisement
The FDA is ramping up its approvals of medications related to precision medicine treatment and diagnostics. To tap into this growing field of patient care, some hospitals and health systems are implementing their own precision medicine programs.
Anne Wojcicki, CEO and co-founder of direct-to-consumer genetic testing company 23andMe, spoke with Quartz reporter Leah Fessler about her career background and leadership approach during a Feb. 6 interview.
Editor's Note: This post originally appeared on Cardinal health's website. With the breakneck pace of change in healthcare, it’s getting harder to anticipate what’s next. Kristina Redgrave, an expert from Fuse by Cardinal Health, the company’s innovation center, shared her…
Paige.AI, a New York City-based computational pathology startup focused on cancer diagnosis and treatment and backed by $25 million in Series A funding, launched Feb. 5.
The majority of radiology leaders see potential in using machine learning capabilities to analyze breast imaging above other types of medical imaging, according to a Reaction Data survey.